Aditya Arora says: “The high beta counters have been little overstretched and valuation is hitting the roof, Nifty Pharma index is looking pretty good and components of the same are looking pretty good. In 2024, pharma index can dominate the trend. So, my stock pick would be Granules, which could be bought at Rs 414; Rs 390 should be the stop loss and Rs 460 should be the target.”
